Fox Business - The Power to Prosper
Search Site

Eli Lilly

Related Topics

  1. John Lechleiter
  2. Sanofi S.A.
  3. Merck
  4. Alkermes
  5. Schering-Plough
  6. Pfizer
Get updates on Eli Lilly
Pfizer to Spin Off Remaining Zoetis Stake

Pfizer Inc. (PFE) plans to split off its remaining interest in its former animal-medicine unit Zoetis Inc. (ZTS) through a voluntary exchange offer with its shareholders.Zoetis, which makes drugs and vaccines given to livestock, completed its roughly $2.2 billion initial public offering in February. Pfizer said it owns about 401 million Class B Zoetis shares, or about 80.2% of the stock outstanding."Given the strong demand in the IPO and a favorable market environment, we concluded that now is the appropriate time to distribute our remaining stake in Zoetis," Pfizer Chairman and Chief Executive Ian Read said.The world's largest drug maker by sales said Wednesday it received a waiver of the 180-day lock-up from the joint-book running managers of the Zoetis IPO.Pfizer shareholders will be able to exchange Pfizer stock for Zoetis shares at a 7% discount, subject to an upper limit of 0.9898 of a Zoetis share for each Pfizer share. If the upper limit isn't in effect, every $100 of Pfizer st...

Read More ›

  1. Lilly CEO Lechleiter to undergo surgery for dilated aorta

    Drug maker Eli Lilly and Co said Chief Executive John Lechleiter will undergo a surgery on May 13 to treat a dilated aorta but is expected to recover and return to w...

  2. Eli Lilly CEO to Undergo Surgery Next Week; Expected to Return to Duties Later This Summer

    Eli Lilly & Co. (LLY) Chairman and Chief Executive John C. Lechleiter is scheduled to undergo surgery next week for a dilated aorta and is expected to make a full re...

  3. Merck 1st-Quarter Profit Down on Loss of Singulair Exclusivity

    Major drug makers are finding it more difficult than expected to overcome the blow of recent patent expirations, with Merck & Co. (MRK) becoming the second company a...

  4. Eli Lilly Profit Beats Expectations, Boosted by Lower Taxes

    Eli Lilly and Co on Wednesday reported higher-than-expected quarterly earnings due to favorable taxes and cost controls, but sales missed expectations because of ane...

  5. Eli Lilly 1st-Quarter Net Rose 53%

    Eli Lilly & Co.'s (LLY) first-quarter earnings rose 53%, thanks in part to a gain from transferring some commercial rights, while margins improved despite flat reven...

  6. Eli Lilly 1st-Quarter Net Rose 53% on Gain; Revenue Flat

    Eli Lilly & Co.'s (LLY) first-quarter earnings rose 53%, thanks in part to a gain from transferring some commercial rights, while margins improved despite flat reven...

  7. Glaxo in Drug-Discovery Venture Capital Deal

    GlaxoSmithKline PLC (GSK, GSK.LN) will partner with venture capitalists from San Diego in an unusual deal worth up to $495 million to start several drug-discovery fi...

  8. WEEK AHEAD: Tech, Energy, Defense to Report Earnings Next Week

    Next week brings a heavy calendar of quarterly results from some of the biggest tech and energy companies in the U.S. as earnings season heats up.Also, a first-quart...

  9. Lilly's Diabetes Dulaglutide Treatment Shows Positive Results in Additional Phase III Trials

    Eli Lilly & Co. (LLY) said its investigational long-lasting treatment for diabetes showed positive results in additional Phase III studies.The latest two long-term s...

  10. Eli Lilly Laying Off 1,000 U.S. Sales Representatives

    Eli Lilly & Co. (LLY) plans to lay off about 1,000 sales representatives in the U.S., in a major restructuring that aims to cut the drug maker's costs in preparation...

  11. Lilly Restructuring Sales Force, Cuts To Come

    Eli Lilly & Co. said late Thursday it will restructure its sales force and cut personnel, but the drug maker wouldn't confirm a report that 1,000 layoffs are planned...

  12. Report: Lilly to Cut U.S. Salesforce

    Pharmaceutical giant Eli Lilly (NYSE:LLY) plans reduce its U.S. sales group by nearly 1,000 representatives as part of a major restructuring, according to a report T...

  1. Analysis: Amazon gets help to lure big business to the cloud

    As Amazon.com Inc seeks to transform itself into a leading provider of technology to the world's largest corporations, it's discovering that it needs help.The online...

  2. Lilly CEO Recovering from Surgery for Dilated Aorta

    Eli Lilly & Co. (LLY) said Chairman and Chief Executive John C. Lechleiter is recovering from Monday surgery for a dilated aorta."Dr. Lechleiter's surgeons have advi...

  3. Eli Lilly Ends Development of Lymphoma Drug Enzastaurin; Missed Study Endpoint

    Eli Lilly & Co. (LLY) said it will stop developing enzastaurin because a late-stage study showed the drug didn't significantly increase the survival of patients with...

  4. Lilly To Take $30M Charge After Disappointing Drug Trial

    Eli Lilly (NYSE:LLY) said Friday it will take a current-quarter charge of $30 million after its exploratory relapse cancer drug enzastaurin failed to meet expectatio...

  5. Lilly CEO to Have Artery Surgery, Seen Returning by Fall

    Drug maker Eli Lilly & Co. (LLY) said Chairman and Chief Executive John C. Lechleiter will hand over his duties to others while he undergoes surgery to repair an enl...

  6. Lilly CEO to Have Artery Surgery, Seen Returning By Fall

    Drug maker Eli Lilly & Co. (LLY) said Chairman and Chief Executive John C. Lechleiter will hand over his duties to others while he undergoes surgery to repair an enl...

  7. Lilly CEO to undergo surgery, CFO Rice to become interim CEO

    Eli Lilly & Co's longtime Chief Executive John Lechleiter will undergo surgery next Monday for a dilated aorta, but is expected to make a full recovery from the pote...

‹ Prev12345…Next ›
Freebase CC-BY
Source: Eli Lilly on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL